Pfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease vaccine Ruchika Sharma10 Sept 2023 2:30 PM ISTNew York: Valneva SE and Pfizer Inc. have announced positive pediatric and adolescent immunogenicity and safety data for their Lyme...
Daiichi Sankyo submits sNDA for Omicron XBB.1.5-adapted COVID vaccine in Japan Ruchika Sharma10 Sept 2023 10:00 AM ISTTokyo: Daiichi Sankyo has announced that it has submitted a supplemental New Drug Application (sNDA) to Japan’s Ministry of Health, Labour and...
European Commission expands Merck Ervebo indication to include children 1 year of age and older Ruchika Sharma9 Sept 2023 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved an expanded...
Mpox vaccine effective in decreasing severity of monkeypox infection: The Lancet Infectious Diseases study Dr. Kamal Kant Kohli8 Sept 2023 9:45 AM ISTUSA: A recent international study published in The Lancet Infectious Diseases showed less severe mpox (formerly known as monkeypox) infections in...
Pfizer-BioNTech updated COVID vaccine approved by UK regulator Ruchika Sharma6 Sept 2023 10:00 AM ISTBengaluru: The UK drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets...
Pfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU Ruchika Sharma1 Sept 2023 2:46 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Indian Immunologicals expects to commercially launch dengue fever vaccine by early 2026 Ruchika Sharma27 Aug 2023 12:30 PM ISTIIL's managing director, K Anand Kumar, said the vaccine's early stage trials conducted on about 90 individuals, aged 18-50 years, did not demonstrate...
Pfizer gets European Commission marketing nod for RSV vaccine Abrysvo to protect infants, older adults Ruchika Sharma27 Aug 2023 11:00 AM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, the company’s bivalent...
Vaccinating children against COVID-19 effective in severe cases: BMJ Dr. Kamal Kant Kohli26 Aug 2023 10:15 AM ISTAustralia: A review published in BMJ Paediatrics Open has revealed the effectiveness of COVID-19 vaccines against severe cases of the disease in...
4-component protein-based vaccine highly effective against serogroup B invasive meningococcal disease: JAMA Jacinthlyn Sylvia24 Aug 2023 9:15 AM ISTIn the ongoing efforts to combat serogroup B invasive meningococcal disease (IMD), a recent study revealed promising results regarding the...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA Dr. Kamal Kant Kohli22 Aug 2023 12:00 PM ISTRespiratory Syncytial Virus is a highly contagious virus that causes respiratory infections in individuals of all age groups. Furthermore it is the...
Pfizer maternal vaccine Abrysvo bags USFDA approval for RSV prevention in infants Ruchika Sharma22 Aug 2023 11:26 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO (Respiratory Syncytial Virus Vaccine),...
